First, the Good News: Most People Do Just Fine Studies show about 1030% of patients experience side effects, and in real-world practice, that number may be a bit higher but the key thing to know is that for most people, side effects are mild, manageable, and improve over time
Clinical Perspective The panel concluded that the benefits of GLP-1RAs far outweigh potential ocular risks, given their proven: ~11.5 % HbA1c reduction 515 % weight loss (SURPASS & STEP programs) ~1426 % relative risk reduction in major CV events Hence, appropriate screening, not avoidance, should guide practice
Amazing Meds+2GoodRx+2
There was a lot of chatter about what was going on, and this is the opportunity for her to come out and say authentically what was going on. He added that the team emphasized this message in the video, and deliberately included mentions and visuals of the app to highlight the importance of going through the program on the app while on GLP-1s